Article
Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks
27 Oct 2019
Abstract excerpt
Traditional cancer models including cell lines and animal models have limited applications in both basic and clinical cancer research. Genomics-based precision oncology only help 2–20% patients with solid cancer. Functional diagnostics and patient-derived cancer models are needed for precision cancer biology. In this review, we will summarize applications of conditional cell reprogramming (CR) in cancer research...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
